SBIR/STTR Research Award
Developing Novel Mechanism of Action Antivirals for Bunyavirus Therapeutics
Award amount
$548,493Program and phase
SBIR · Phase IIAward year
2023Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- CFD Research Corporation
- Proposal award date
- 2023-05-15
- Contract end date
- 2025-05-18
- UEI
- V3KCP1HNFM33
- Solicitation number
- 21.2
- Topic code
- CBD212-006
Research abstract
This project seeks to develop a new broad-spectrum antiviral drug against viruses from the Bunyavirales family. These viruses have been designated as being among the highest potential to cause the next pandemic. CFD Research is advancing a natural product-derived antiviral chemistry that has demonstrated strong in vitro potency against Bunyaviruses with low cytotoxicity. We seek to produce an optimized lead candidate from this project.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Multiphysics Modeling Framework for Raindrop-Induced Material Damage
- Ground Technologies for Surface Operation Risk Mitigation
- Supportive Tactical Aide Foresight Framework (STAFF)
- Soil Cohesion Effects on Cratering and Transport of Regolith due to Plume-Surface Interaction
- Modular and Scalable Machine Learning Framework for Infrared Search and Track
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of Small Molecule Therapeutics Specifically Targeting Members of the Bunyavirales Order
- Development of novel Small Molecule Antiviral Endocytosis Inhibition pathway
- Small Molecule Therapeutics Targeting Members of the Bunyavirales Order
- DNA Aptamers for Passive Immunity Against Bunyaviruses
Research funding history
947 SBIR/STTR records share this UEI (1987–2026). Reported award amounts total $350,893,199. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, National Science Foundation, Department of Commerce, Department of Energy